Natalie serkova, Ph. D. Current Title
Download 376.88 Kb.
|
Invited Lectures:1996 “MRS application to the evaluation of volume regulation and metabolic alterations in primary astrocytes”, Radiology Department, Johns Hopkins University, Baltimore, MD. 1997 “Possibilities of NMR spectroscopy in biopharmaceutical research”, Department of Biopharmaceutical Sciences, University of California, San Francisco, CA. 1998 “Neurotoxic screening of immunosuppressive drugs by 31P-MRS on perfused rat brain slices ex vivo”, Department of Neurosurgery, Stanford University, Stanford, CA. “NMR for drug toxicity in transplantation medicine”, Department of Anesthesiology, University of Pittsburg, Pittsburg, PA. 1999 “MRS on perfused organs”, Department of Radiology, DVA Medical Center, San Francisco, CA “Does impairment of energy metabolism result in cyclosporine neurotoxicity?”, Department of Biopharmaceutical Sciences, University of California, San Francisco, CA. “Cyclosporine in the brain: from neurotoxicity to neuroprotection”, Department of Chemistry/Biology, University of Bremen, Germany. “Role of calcineurin and immunophilins in neurotoxicity of immunosuppressants”, Department of Cardiothoracic Surgery, Stanford University, Stanford, CA. 2000 “Evaluation of the effect of cyclosporine, sirolimus, and RAD alone and in combination on cell metabolism”, Preclinical Safety Department, Novartis Pharmaceuticals, Basel, Switzerland. “The importance of evaluating mechanisms of toxicity: RAD and sirolimus have opposite effects on cell metabolism”, 18th International Congress of the Transplantation Society, Rome, Italy. 2001 “MRS (magnetic resonance spectroscopy) as preclinical test for the efficacy and metabolic toxicity of novel drugs”, School of Pharmacy, University of Colorado Health Sciences Center, Denver, CO. “MRS/MRI in biomedical research”, Bayer AG, Wuppertal, Germany. 2002 “Kidney metabolic toxicity of novel immunosuppressants: everolimus versus sirolimus in combination with cyclosporine”, Preclinical Safety Department, Novartis Pharmaceuticals, Basel, Switzerland. “MRS in islet transplantation”, Departments of Anesthesia and Surgery, University of California, San Francisco, CA. “Biomedical Magnetic Resonance (MRI/MRS) Center at UCHSC: from cells to the human”, Animal Cancer Center, Colorado State University, Fort Collins, CO. 2003 “Magnetic resonance spectroscopy (MRS) for metabolic evaluations: from the cell to the human”, Department of Pharmacology, University of Colorado Health Sciences Center, Denver, CO. “Magnetic resonance spectroscopy: Cell metabolism in hypoxia and reperfusion”, Colorado Center for Altitude Medicine and Physiology (CCAMP) Seminar, University of Colorado Health Sciences Center, Denver, CO. “MRI/MRS in diagnosis and treatment of prostate cancer”, 13th International Prostate Cancer Update, Vail, CO. “Magnetic resonance spectroscopy as a tool to identify mechanisms of immunosuppressant toxicity”, 42nd Annual Meeting of the Society of Toxiclology (SOT), Salt Lake City, UT. “MRS-based metabonomics to evaluate metabolic toxicity of novel immunosuppressants”, Toxicology and Inflammatory Diseases Unit, Roche Bioscience, Palo Alto, CA. “Metabonomics: A new approach in pharmacodynamics and toxicodynamics”, Sanofi-Synthelabo Research Inc., Malvern, PA. “Magnetic resonance spectroscopy (MRS) for metabolic prediction of anticancer drug resistance”, 8th World Congress on Advances in Oncology, Crete, Greece. 2004 “Cancer Metabolism and Its Changes Upon TKI Treatment: NMR from the Bench top to The Patient Bed”, Department of Radiology, Johns Hopkins School of Medicine, Baltimore, MD. “Quantitative MRS based Metabolomics in Drug Discovery: Pharmacodynamics and Toxicodynamics”, SMASH 2004 Conference Program, Breckenridge, CO. “Magnetic Resonance (MRI/MRS) in Translational Research in Cancer and Anti-Cancer Treatment”, Colorado Cancer Center Symposium Series, Denver, CO. “Quantitative NMR based Metabolomics: From Method Validation to Biomedical Application”, 2004 Bruker User Meeting, San Jose, CA. “Metabolic Signature of Small Molecule Tyrosine Kinase Inhibitors by MRS – from Efficacy to Resistance Development”, Cambridge Healthtech Institute Conference, Miami, FL. 2005 “MRS Based Metabolomics as a PD Tool for Novel TKIs”, The Third Annual Opinion Leader Consortium on Novel and Targeted Therapies for Head and Neck Cancer, Astra Zeneca, Cancun, Mexico. “From Proteomics to Metabonomics”, Continuing Medical Education Program Controversies in Transplantation, Breckenridge, CO. Roundtable: “NMR-based Metabonomics as a Potential Clinical Tool for Monitoring Efficacy and Toxicity of Drug Therapy”, 9th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Louisville, KE. “Identification of Biomarkers for the Toxicodynamics Monitoring of Immunosuppressants Using an MRS-based Quantitative Metabonomics Approach”, 9th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Louisville, KE. “Blood Metabolic Profiling in Transplantation by Quantitative 1H-NMR Spectroscopy”, Metabolic Profiling in Drug Discovery, London, UK “Metabolomics: Principles and Practice”, UCDHSC Research Symposium on Systems Biology in Biomedical Research, Denver, CO “Quantitative 1H-NMR Metabolomics to Monitor Graft Outcome After Transplantation”, Cambridge Healthtech Institute Conference on Metabolic Profiling, Miami, FL. 2006 “Assessment of Efficacy of Novel Targeted Drugs by MRI/MRS”, University of Colorado Cancer Center, Developmental Therapeutics Program Retreat, Aurora, CO. “MR Imaging for In Vivo Cancer Models and Novel Therapeutics”, 4th Annual Opinion Leader Consortium on Novel and Targeted Therapies for Head and Neck Cancer, Key Biscayne, FL. “Blood analysis for Cancer Prediction”, Interview for Colorado 7News Channel “Quantitative Blood Metabolomics in Organ Transplantation”, Advances in Functional Genomics, San Francisco, CA. “Quantitative Metabolic Markers by High-Resolution Magnetic Resonance Spectroscopy”, American Chemical Society, San Francisco, CA. “Biomedical MRI/ MRS: from Cell Metabolism to Animal Physiology”, Department of Medicine Monthly Research Conference, UCHSC, Denver, CO. “Magnetic Resonance in Biomedicine: From Metabolomics to Physiology”, Key Note Speaker for Women’s Health Investigator Network Fall Forum 2006, Denver, CO. “Metabolic Consequences of Therapeutic Responsiveness and Resistance Development to Novel Targeted Therapies”, 5th International Congress on Cancer Metabolism, Louisville, KY. “Metabolic and Physiological Response to EGFR Inhibition by Novel Small Molecule Tyrosine Kinase Inhibitors”, UCHSC Department of Pharmacology Retreat, Copper Mountain, CO. “Metabolic Markers in Translational Transplantation”, UCHSC Department of Anesthesiology Research Seminar, Denver, CO. “Magnetic Resonance – from Cell Biochemistry to Animal Physiology”, UCHSC Biomolecular Structure Program Grand Rounds, Aurora, CO. “Magnetic Resonance to Assess Therapeutic Response”, Signaling Transduction Modulators Symposium, Aurora, CO. “1H-NMR Based Metabolomics: Translational Applications to Transplantation”, 7th Annual Cambridge Healthtech Institute’s Meeting on Metabolic Markers, Orlando, FL. 2007 “Magnetic Resonance in Medicine: From Metabolomics to Molecular Imaging”, UCHSC Department of Endocrinology, Aurora, CO. “Small Animal Imaging at UCHSC: Optical, MRI, microPET/CT”, Department of Immunology Grand Rounds, the National Jewish Center, Denver, CO. “NMR Spectroscopy and Neurological Outcome in Children with Congenital Heart Disease”, Department of Surgery and Anesthesiology Grand Rounds, the Children’s Hospital, Denver, CO. “NMR-Based Metabolomics of Immunosuppressant Toxicity After Organ Transplantation”, Cambridge Healthtech Institute Biomarker Discovery Summit, Philadelphia, PA. “Application of Imaging Modalities in Pre-Clinical Research”, UCHSC Department of Obstetrics and Gynecology Grand Rounds, Aurora, CO. 2008 “Small Animal Imaging in Colorado”, Grand Rounds, Immunology Department, National Jewish Medical Center, CO. “Translational Imaging Endpoints in Oncology: From Pre-Clinical Imaging to IRAT”, Educational Rounds, Radiology Department, UCHSC, Aurora, CO. “NMR-Based Metabolomics: Translational Application in Cancer and Anti-Cancer Treatment”, Cambridge Healthtech Institute, Biomarker Discovery Summit, Philadelphia, PA. “Pre-Clinical and Clinical DCE-MRI on Novel VEGFR-Targeting Drugs”, Department of Radiology, Penn University, Philadelphia, PA. “Novel Imaging Approaches in Pre-clinical and Clinical Setting”, The Rocky Mountain Nuclear Medicine Technologist Association, Englewood, CO. “Imaging in Vivo Omics – The End of the Cold War in Translational Medicine”, American Society of Anesthesiology, Orlando, FL. 2009 “Establishing Metabolic Profiles of Delayed Graft Function in Blood of Kidney Recipients”, Frontier in Renal Transplantation, Division of Transplant Surgery, Denver, CO. “Brain Imaging: Anatomical, Metabolic and Functional Imaging Modalities”, Colorado Intellectual and Developmental Disabilities Research Center (IDDRC) Seminar Series, Denver, CO. “Brain Metabolomics”, Colorado Intellectual and Developmental Disabilities Research Center (IDDRC) Seminar Series. “Imaging End-Points in Oncology”, Biomarkers in Clinical Trials conference, SMi Group, London, UK. “Intracellular Pathways of Glucose Metabolism Determine Imatinib Resistance in Leukemia: Potential Applications for Drug Resistance Testing in Circulating Tumor Cells”, (together with Dr. Laszlo G. Boros, UCLA/ SIDMAP) NIH Meeting on Circulating Tumor Cells/ Emerging Technologies, Bethesda, MD. “Imaging Update in Colorado: Animal Imaging and the New C-TRIC”, Department of Anesthesiology Research Seminar Series, School of Medicine, University of Colorado at Denver, Aurora, CO. “Functional Imaging to Assess Responsiveness to IGF-1R Inhibition in CRC Models”, Developmental Therapeutics Program Retreat, University of Colorado Cancer Center, Aurora, CO. 2010 “Anatomical and Functional Imaging in Oncology”, Hormones and Related Malignancies Seminar Series, School of Medicine, University of Colorado at Denver, Aurora, CO. “Functional and Molecular Imaging on Animal Models of Cancer”, Colorado State University, Veterinarian Teaching Hospital, Fort Collins, CO. “Functional Imaging for IGF-1R Responsiveness in Colorectal Cancer”, University of Colorado Cancer Center Symposium, UCD, Aurora, CO. “Functional Imaging in Animal Cancer Models”, Department of Radiology, Colorado Translational Research Imaging Center (C-TRIC), UCD, Aurora, CO. 2011 “Oncologic Imaging Utilizing 4.7T MRI”, Section for Magnetic Resonance Technologists (SMRT) of the International Society for Magnetic Resonance in Medicine (ISMRM), 2011 Regional Educational Seminars, Broomfield, CO. “Clinical Application of Metabolomics in Cancer”, (co-authored with Gail S. Eckhardt, MD, Plenary Session on Advance Technologies, American Association for Cancer Research (AACR) 2011 Annual Meeting, Orlando, FL. “Next Generation Imaging for Cancer Detection, Staging and Treatment Response”, CCTSI Clinical Investigator Program Retreat, Aurora, CO. “Multimodality Imaging of Mice”, Educational Courses at the 2011 Annual Meeting of the ISMRM, Montreal, Quebec, Canada. “Physico Chemical Principles of Metal Based Paramagnetic/ Iron Contrast”, Educational Courses at the 2011 Annual Meeting of the ISMRM, Montreal, Quebec, Canada. “New Oncologic Imaging for the Assessment of Therapy Response”, Bio-Imaging Meeting at the National Institute of Standard and Time (NIST), Boulder, CO and Washington, DC. “Current Pre-Clinical Resources at the AMC” VisualSonic Imaging Symposium in Colorado, Aurora, CO. “1H-NMR Based Metabolomics: Application in Translational and Clinical Medicine” Grand Rounds for the Department of Computational Medicine and Bioinformatics, Medical School, University of Michigan, Ann Arbor, MI. 2012 “Imaging genes and proteins non-invasively: Molecular imaging in living animals” Structural Biology and Biochemistry Graduate Program, Anschutz Medical Center, University of Colorado Denver, Aurora, CO. “Oncologic Imaging Utilizing 4.7T MRI”, Section for Magnetic Resonance Technologists (SMRT) of the International Society for Magnetic Resonance in Medicine (ISMRM), 2012 Regional Educational Seminars, Loveland, CO. 2013 “MRI on Imaging Inflammation Using Targeted and Untargeted Iron Oxide Nanoparticles” Physics Grand Rounds, University of Colorado, Colorado Springs, CO. “Animal Imaging and Advances in Brain Imaging” IDDRC Seminar, University of Colorado, Anschutz Medical Center, Aurora, CO. “Contrast-Enhanced T2-MRI with Iron Oxide Nanoparticles to Image Tumor Associated Macrophages” Cancer Center Symposium, Comprehensive Cancer Center, Tampa, FL. 2014 “Imaging Inflammation in Cancer: Pre-Clinical MRI Using Iron Oxide Nanoparticles” Cancer Center Symposium, University of Colorado Cancer Center, Aurora, CO. “Animal Oncologic Imaging” Molecular Oncology Retreat, University of Colorado Boulder, Boulder, CO. “Imaging Inflammation Using Iron Oxide Enhanced MRI” Anesthesiology Grand Rounds, University of Colorado, Anschutz Medical Center, Aurora, CO. “Imaging of Cancer Inflammation: The Future of MRI and PET” Endocrinology Grand Rounds, University of Colorado, Anschutz Medical Center, Aurora, CO. “Cancer Physiology” 22nd Scientific Meeting of the International Society of Magnetic Resonance in Medicine (ISMRM), Milan, Italy. “Imaging of Cancer Treatment Response” Keynote Speaker Directory: academics -> colleges -> medicalschool -> departments departments -> Previous id grand Rounds medicalschool -> Gail Armstrong, dnp, PhD(c), acns-bc, cne colleges -> Course Number: Course Title: Semester Credit Hours colleges -> Assessment Report Spring 2011 colleges -> Susan muaddi darraj 3530 Sweet Air Road 410-258-0688 colleges -> Brenda J. Allen University of Colorado Denver colleges -> Educational background departments -> Curriculum vitae name Download 376.88 Kb. Share with your friends:
|